Oncofertility in Gynecologic Malignant Tumors
نویسندگان
چکیده
منابع مشابه
Oncofertility in Gynecologic Malignant Tumors
Long-term survival is the priority in treatment of patients with malignant tumors. In the field of gynecology, fertility preservation has also recently become an important objective due to improved treatment outcomes and different needs of patients. Methods for fertility preservation include cervical conization, ovarian protection against radiation or chemotherapy for ovarian cancer since the o...
متن کاملPATTERN OF MALIGNANT TUMORS IN KERMAN PROVINCE
From March 1980 to March 1989 a total number of 2254 (7.6%) new malignant cases from Kerman province were diagnosed by examination of surgical specimens, blood films and bone marrow smears. The crude relative frequency of cancers was studied and compared with other areas of Iran. Gastric (11.36%) and urinary bladder (7.01 %) carcinomas were significantly more common in Kerman province than...
متن کاملFrequency of Cytomegalovirus (CMV) in benign and malignant tumors
Cytomegalovirus (CMV) is a widespread pathogen that is found in milk, saliva, urine, cervical secretions, and semen fluid. It is supposed that CMV is a risk factor for breast cancer. The aim of this study was to determine the frequency of CMV among benign and malignant breast tumors. Paraffin embedded breast carcinoma (n=24) and fibroadenoma (n=24) samples were collected from Toos and Firoozgar...
متن کامل[Study on the plasma plasminogen activators in patients with malignant gynecologic tumors].
Increased plasminogen activator (PA) secretion has been observed in malignant cells and tissue and PA is thought to be involved in the processes of tumorigenesis, cancer invasion and metastasis. Recently two types of plasminogen activator--tissue type PA(tPA) and urokinase type PA(uPA)--have been detected in human plasma. In this study, to investigate the relationship between circulating PA and...
متن کاملDrug Resistance and its Solution in Chemotherapy of Gynecologic Malignant Tumors
Drug resistance is the fundamental reason for tumor recurrence and treatment failure in gynecologic malignant tumors. Drug resistance prevention requires familiarity with physicochemical properties of chemotherapeutic drugs, characteristics of vivo metabolism, correctly chosen chemotherapeutic schemes including multi-drug combination chemotherapy, experimental for doubtful diagnosis and timely ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Therapy
سال: 2015
ISSN: 2151-1934,2151-1942
DOI: 10.4236/jct.2015.614128